Latest news
Long-acting therapies continue to gain momentum in HIV, says GlobalData
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.
Oak leaves harbor distinct microbial worlds on their opposite surfaces
Researchers have discovered that the upper and lower surfaces of a single oak leaf function as two fundamentally different microbial habitats.
Triple-dose regimen may permanently clear HIV in infected newborns
New research suggests a one-time regimen of therapies given to newborns within three days of birth could permanently clear HIV infection.
New viral marker strategies improve prediction of functional cure in chronic hepatitis B
Researchers identify how combining classical and emerging viral biomarkers can better predict functional cure and guide individualized hepatitis B treatment.
Tolkien-inspired coral among the stars: New species discovered on Costa Rica’s deep-sea seamounts
Scientists exploring seamounts off the coast of Costa Rica have discovered a new coral so genetically and morphologically distinct that it required the creation of an entirely new family for its classification.
Oak leaves harbor distinct microbial worlds on their opposite surfaces
Researchers have discovered that the upper and lower surfaces of a single oak leaf function as two fundamentally different microbial habitats.
Triple-dose regimen may permanently clear HIV in infected newborns
New research suggests a one-time regimen of therapies given to newborns within three days of birth could permanently clear HIV infection.
New viral marker strategies improve prediction of functional cure in chronic hepatitis B
Researchers identify how combining classical and emerging viral biomarkers can better predict functional cure and guide individualized hepatitis B treatment.
Long-acting therapies continue to gain momentum in HIV, says GlobalData
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.
ABM strengthens Irish life sciences business with major multi-site life sciences contract
ABM, a leading international provider of facility, engineering, and infrastructure solutions, has secured a major multi-site services agreement with a leading global life sciences company operating manufacturing facilities across Ireland.
Corn stalks. It’s what’s for dinner … If you’re a microbe
Engineers have developed a strain of a common bacterial species, Pseudomonas putida, that can feed exclusively on the three major sugars present in corn stalks, with broader implications for the future of biomanufacturing.
New AI-driven technology could help combat harmful algal blooms
Researchers are developing an innovative technology that could help stop harmful algal blooms before they spread.
U.S. disease tracker launches to strengthen monitoring of vaccine-preventable diseases
A new website will track the spread of vaccine-preventable diseases across the United States to offer the public, the media, healthcare providers, public health officials, and policymakers reliable and visual information about current disease trends.
Free webinar: The secret world of the vaginal microbiome
A fascinating free webinar will shine a light into the secret world of the human microbiome and how it influences gynecological health. It will focus on what the vaginal microbiome can reveal about health, disease, and the gaps in care we still need to address.
Scientists bring Florida high school students to the front lines of pandemic preparedness
Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about viruses and considering careers in science.